Cargando…
The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective
Dutch researchers were among the first to perform clinical studies in bare metal coronary stents, the use of which was initially limited by a high incidence of in-stent restenosis. This problem was greatly solved by the introduction of drug-eluting stents (DES). Nevertheless, enthusiasm about first-...
Autores principales: | Kawashima, H., Zocca, P., Buiten, R. A., Smits, P. C., Onuma, Y., Wykrzykowska, J. J., de Winter, R. J., von Birgelen, C., Serruys, P. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419418/ https://www.ncbi.nlm.nih.gov/pubmed/32780336 http://dx.doi.org/10.1007/s12471-020-01442-w |
Ejemplares similares
-
Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020) -
Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS
por: Hommels, T. M., et al.
Publicado: (2020) -
Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease
por: Campos, Carlos M., et al.
Publicado: (2013) -
Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions
por: Fam, Jiang Ming, et al.
Publicado: (2017) -
Coronary Artery Vessel Healing Pattern, Short and Long Term, After Implantation of the Everolimus‐Eluting Bioresorbable Vascular Scaffold
por: Kraak, Robin P., et al.
Publicado: (2015)